This week's sponsor is Premier Research. | | Placebo Response: Mitigating the Threat to Pain Trials Fibromyalgia Awareness Day, May 12, is a timely reminder of how placebo response can skew analgesia clinical trials. Our placebo problem eBook can help you take the pain out of pain trials. Premier Research. It's what we do. Best. | Today's Rundown Ascletis files for Hong Kong IPO as floodgates open to prerevenue biotechs Merck and OncoSec expand Keytruda/IL-12 collaboration into triple-negative breast cancer With patisiran FDA nod imminent, Alnylam preps CNS pipeline for the clinic [Sponsored] Optimize Human Gene Transfer Trials: Create Efficiencies with Coordinated IRB & IBC Review Faron Pharma flummoxed as Traumakine fails in ARDS Autolus seeks $100M IPO to take next-gen CAR-Ts deep into the clinic Featured Story | Tuesday, May 8, 2018 Ascletis Pharma has become the first company to seek to list in Hong Kong under the exchange’s new, more relaxed rules on biotech IPOs. The antiviral disease specialist will use the cash to win approvals for hepatitis C drugs licensed from Roche and Presidio Pharmaceuticals. |
|
| This week's sponsor is Deloitte. | | | Top Stories Tuesday, May 8, 2018 Merck and OncoSec Medical are partnering up on a second clinical trial, this time combining two of their immunotherapies in metastatic triple-negative breast cancer, following a similar collaboration in melanoma announced just one year ago. Tuesday, May 8, 2018 On the back of promising preclinical data, Alnylam is gearing up to move RNAi therapies for central nervous system disorders into the clinic. Monday, May 7, 2018 Avoid delays in gene transfer trial start-up with tips from leading IRB and IBC experts. Tuesday, May 8, 2018 Shares in Finnish biotech Faron Pharma are in free fall this morning after a late-stage trial of its lead drug Traumakine for acute respiratory distress syndrome (ARDS) comprehensively failed. Tuesday, May 8, 2018 Autolus has filed to raise $100 million in a Nasdaq IPO. The British biotech wants the cash to bankroll clinical trials of a clutch of next-generation CAR-Ts designed to broaden the use of cell therapies while improving their safety and efficacy. This week's sponsor is LabConnect. | | SciOps Provides Solutions for Lost Samples, Missed Timelines and Scientific Personnel Needs Managing outsourced studies can be challenging. Read how our team’s functional and strategic resourcing services allow you to focus on other core competencies. | Resources Sponsored by: Seton Hall Law 4-day interactive educational program trusted by multi-national companies as part of their compliance training for employees. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating globally. Visit event homepage for session topics. Sponsored by: USDM Life Sciences What are the biggest trends in life sciences this year? Presented by: Patheon There are many parenteral dosage forms from which the pharmaceutical scientist can choose to develop their drug product. In this article, the author discusses the choices available and strategies which can be employed at the different stages of development. Sponsored by: Veeva Systems Explore a new model for events management, and learn how to deliver more value. Sponsored by: Veeva Systems To deliver value to key opinion leaders, medical affairs needs to tailor their engagement with deeper analytics and insights. Sponsored by: Veeva Systems Learn how leading companies, from the world’s top pharma to emerging biotechs, are empowering their medical affairs teams. Sponsored by: Veeva Systems Learn how to reduce change management burden, keep systems current, and maintain compliance by applying a risk-based approach to change management of GxP systems. Sponsored by: Veeva Systems UCB took a more holistic approach to managing regulatory processes. Read how their efforts are paying off. Sponsored by: Veeva Systems Find out how to eliminate regulatory’s tracking spreadsheets for good. Sponsored by: Veeva Systems Learn how cloud-enabled solutions provide real-time insights and actionable analytics to improve clinical trial safety and performance in this short presentation. Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Translational Biomarkers: Advancing Neuroscience Drug Discovery and Development May 14, 2018 | South San Francisco, CA
MIXiii-Biomed 2018 May 15-17, 2018 | Tel-Aviv, Israel Drug Development Immersion May 17-18, 2018 | Boston, MA BIO International Convention June 4-7, 2018 | Boston, MA
FierceBiotech Executive Breakfast at BIO 2018 – CAR-T 2.0: Innovation Never Stands Still June 6, 2018 | Boston, MA BioBasics: Biotech for the Non-Scientist June 13-14, 2018 | West Windsor, NJ BioBasics: Biotech for the Non-Scientist June 13-14, 2018 | Toronto, Canada Sensors Expo & Conference Conference & Expo: June 26-28, 2018 | Pre-Conference Symposia: June 25, 2018 | San Jose, CA 18th International Biotechnology Symposium and Exhibition August 12-17, 2018 | Montreal, Canada FierceBiotech 3rd Drug Development Forum October 1–3, 2018 | Hilton Boston Logan Airport Hotel | Boston, MA Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA | Register and start preparing Today! |